Xtant Medical Holdings
XTNT
20 hedge funds and large institutions have $135M invested in Xtant Medical Holdings in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 4 closing their positions.
0.35% less ownership
Funds ownership: 95.74% → 95.39% (-0.35%)
5% less funds holding
Funds holding: 21 → 20 (-1)
23% less capital invested
Capital invested by funds: $176M → $135M (-$41M)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$14.7M |
| 2 |
Renaissance Technologies
New York
|
+$160K |
| 3 |
VF
Virtu Financial
New York
|
+$65.1K |
| 4 |
BlackRock
New York
|
+$40.6K |
| 5 |
State Street
Boston,
Massachusetts
|
+$40.5K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$145K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$112K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$98.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$79K |
| 5 |
Millennium Management
New York
|
-$28K |
XTNT Hedge Fund Activity: Q2 2021 in Review
20 of the 5,767 institutional investors tracked by Wall St. Rank reported a position in Xtant Medical Holdings (XTNT) for Q2 2021, worth a combined $135M — down 23% from $176M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of XTNT and 3 opened new positions — a net loss of 1 holder — while 6 trimmed existing stakes and 4 added.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $14.7M. The largest seller was Bridgeway Capital Management, cutting an estimated $145K.
- 20 institutional investors held Xtant Medical Holdings (XTNT) as of Q2 2021, down from 21 in Q1 2021.
- Funds reported $135M of Xtant Medical Holdings stock for Q2 2021, down 23% quarter-over-quarter.
- 3 funds opened new Xtant Medical Holdings positions in Q2 2021 and 4 closed out, a net change of -1 holder.
- The largest Xtant Medical Holdings buyer in Q2 2021 was Altium Capital Management, an estimated $14.7M added.
- The largest Xtant Medical Holdings seller in Q2 2021 was Bridgeway Capital Management, an estimated $145K sold.
Based on aggregated 13F filings for Q2 2021.